Regulation of vascular smooth muscle cell growth by aldose reductase

Aruni Bhatnagar, Johannes Ruef, Si Qi Liu, Sanjay Srivastava, Satish Srivastava

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aldose reductase (AR) is a broad-specificity aldo-keto reductase with wide species and tissue distribution. The enzyme has been implicated in the development of pleiotropic complications of long-term diabetes. However, the euglycemic function of the enzyme remains unclear. To examine its potential role in cell growth, changes in AR mRNA and protein were measured in human aortic smooth muscle cells exposed in culture to serum or thrombin. Stimulation by these mitogens led to an increase in the abundance of AR mRNA and protein. Furthermore, inhibition of the AR by tolrestat and sorbinil diminished DNA synthesis and cell proliferation in response to serum. Immunohistochemical staining with anti-AR antibodies revealed no significant expression of AR in the smooth muscle cells of rat carotid arteries. However, 10 and 21 days after balloon injury, intense staining was associated with the proliferating cells of the neointima. Treatment of these animals with 40 mg/kg/day sorbinil diminished the ratio of neointima to the media. Together, these observations suggest that, in vascular smooth muscle cells (VSMC), AR is a growth-responsive gene product and that inhibition of AR prevents VSMC growth and decreases intimal hyperplasia and restenosis.

Original languageEnglish (US)
Pages (from-to)627-636
Number of pages10
JournalChemico-Biological Interactions
Volume130-132
DOIs
StatePublished - Jan 30 2001

Fingerprint

Aldehyde Reductase
Cell growth
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Growth
Neointima
Cells
Tunica Intima
Staining and Labeling
Messenger RNA
Balloons
Cell proliferation
Tissue Distribution
Enzymes
Medical problems
Serum
Mitogens
Carotid Arteries
Cell culture

Keywords

  • Aldose reductase
  • Rat carotid artery
  • Restenosis
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Toxicology

Cite this

Bhatnagar, A., Ruef, J., Liu, S. Q., Srivastava, S., & Srivastava, S. (2001). Regulation of vascular smooth muscle cell growth by aldose reductase. Chemico-Biological Interactions, 130-132, 627-636. https://doi.org/10.1016/S0009-2797(00)00290-8

Regulation of vascular smooth muscle cell growth by aldose reductase. / Bhatnagar, Aruni; Ruef, Johannes; Liu, Si Qi; Srivastava, Sanjay; Srivastava, Satish.

In: Chemico-Biological Interactions, Vol. 130-132, 30.01.2001, p. 627-636.

Research output: Contribution to journalArticle

Bhatnagar, A, Ruef, J, Liu, SQ, Srivastava, S & Srivastava, S 2001, 'Regulation of vascular smooth muscle cell growth by aldose reductase', Chemico-Biological Interactions, vol. 130-132, pp. 627-636. https://doi.org/10.1016/S0009-2797(00)00290-8
Bhatnagar, Aruni ; Ruef, Johannes ; Liu, Si Qi ; Srivastava, Sanjay ; Srivastava, Satish. / Regulation of vascular smooth muscle cell growth by aldose reductase. In: Chemico-Biological Interactions. 2001 ; Vol. 130-132. pp. 627-636.
@article{ead72f52c2ab4eb0990b8bf04f2b8aca,
title = "Regulation of vascular smooth muscle cell growth by aldose reductase",
abstract = "Aldose reductase (AR) is a broad-specificity aldo-keto reductase with wide species and tissue distribution. The enzyme has been implicated in the development of pleiotropic complications of long-term diabetes. However, the euglycemic function of the enzyme remains unclear. To examine its potential role in cell growth, changes in AR mRNA and protein were measured in human aortic smooth muscle cells exposed in culture to serum or thrombin. Stimulation by these mitogens led to an increase in the abundance of AR mRNA and protein. Furthermore, inhibition of the AR by tolrestat and sorbinil diminished DNA synthesis and cell proliferation in response to serum. Immunohistochemical staining with anti-AR antibodies revealed no significant expression of AR in the smooth muscle cells of rat carotid arteries. However, 10 and 21 days after balloon injury, intense staining was associated with the proliferating cells of the neointima. Treatment of these animals with 40 mg/kg/day sorbinil diminished the ratio of neointima to the media. Together, these observations suggest that, in vascular smooth muscle cells (VSMC), AR is a growth-responsive gene product and that inhibition of AR prevents VSMC growth and decreases intimal hyperplasia and restenosis.",
keywords = "Aldose reductase, Rat carotid artery, Restenosis, Vascular smooth muscle cells",
author = "Aruni Bhatnagar and Johannes Ruef and Liu, {Si Qi} and Sanjay Srivastava and Satish Srivastava",
year = "2001",
month = "1",
day = "30",
doi = "10.1016/S0009-2797(00)00290-8",
language = "English (US)",
volume = "130-132",
pages = "627--636",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Regulation of vascular smooth muscle cell growth by aldose reductase

AU - Bhatnagar, Aruni

AU - Ruef, Johannes

AU - Liu, Si Qi

AU - Srivastava, Sanjay

AU - Srivastava, Satish

PY - 2001/1/30

Y1 - 2001/1/30

N2 - Aldose reductase (AR) is a broad-specificity aldo-keto reductase with wide species and tissue distribution. The enzyme has been implicated in the development of pleiotropic complications of long-term diabetes. However, the euglycemic function of the enzyme remains unclear. To examine its potential role in cell growth, changes in AR mRNA and protein were measured in human aortic smooth muscle cells exposed in culture to serum or thrombin. Stimulation by these mitogens led to an increase in the abundance of AR mRNA and protein. Furthermore, inhibition of the AR by tolrestat and sorbinil diminished DNA synthesis and cell proliferation in response to serum. Immunohistochemical staining with anti-AR antibodies revealed no significant expression of AR in the smooth muscle cells of rat carotid arteries. However, 10 and 21 days after balloon injury, intense staining was associated with the proliferating cells of the neointima. Treatment of these animals with 40 mg/kg/day sorbinil diminished the ratio of neointima to the media. Together, these observations suggest that, in vascular smooth muscle cells (VSMC), AR is a growth-responsive gene product and that inhibition of AR prevents VSMC growth and decreases intimal hyperplasia and restenosis.

AB - Aldose reductase (AR) is a broad-specificity aldo-keto reductase with wide species and tissue distribution. The enzyme has been implicated in the development of pleiotropic complications of long-term diabetes. However, the euglycemic function of the enzyme remains unclear. To examine its potential role in cell growth, changes in AR mRNA and protein were measured in human aortic smooth muscle cells exposed in culture to serum or thrombin. Stimulation by these mitogens led to an increase in the abundance of AR mRNA and protein. Furthermore, inhibition of the AR by tolrestat and sorbinil diminished DNA synthesis and cell proliferation in response to serum. Immunohistochemical staining with anti-AR antibodies revealed no significant expression of AR in the smooth muscle cells of rat carotid arteries. However, 10 and 21 days after balloon injury, intense staining was associated with the proliferating cells of the neointima. Treatment of these animals with 40 mg/kg/day sorbinil diminished the ratio of neointima to the media. Together, these observations suggest that, in vascular smooth muscle cells (VSMC), AR is a growth-responsive gene product and that inhibition of AR prevents VSMC growth and decreases intimal hyperplasia and restenosis.

KW - Aldose reductase

KW - Rat carotid artery

KW - Restenosis

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0035969858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035969858&partnerID=8YFLogxK

U2 - 10.1016/S0009-2797(00)00290-8

DO - 10.1016/S0009-2797(00)00290-8

M3 - Article

C2 - 11306081

AN - SCOPUS:0035969858

VL - 130-132

SP - 627

EP - 636

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

ER -